Market Leadership MVE Biological Solutions is a globally recognized leader in cryogenic storage equipment with over 60 years of industry presence, making it a trusted partner for organizations involved in biopharma, research, and medical sectors.

Acquisition Advantage Having been acquired by Cryoport Inc. in 2020, MVE benefits from expanded distribution channels and increased market reach, creating opportunities for joint sales initiatives and cross-promotional efforts.

Award-winning Innovation Recipient of the ISBER Outstanding New Product Award, MVE demonstrates technological leadership and innovation, which can be leveraged to target customers seeking advanced, reliable cryogenic solutions.

Financial Growth With revenue estimated between 10 million and 25 million dollars, MVE shows solid financial stability, offering potential for upselling and expanding into new product lines within the cryogenic storage market.

Industry Focus Target sectors such as biopharma, cell and gene therapy, and medical research are key markets for MVE’s products, presenting strong sales opportunities to supply storage and shipping devices for sensitive biological materials.